Lumakras (Sotorasib Tablet) 120mg

Lumakras (sotorasib) 120mg tablets are prescribed for adults with certain types of non-small cell lung cancer. This targeted therapy works by blocking KRAS G12C mutations to slow tumor growth. It is supplied in 240-tablet bottles for daily oral use.

Strength

120mg

Pack Size

240s

Storage

Ambient

Manufacturer / TM Owner

Amgen Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sotorasib is used to treat non-small cell lung cancer (NSCLC) in adults whose tumors have a specific genetic mutation called KRAS G12C. This mutation is found in a subset of NSCLC cases and is linked to cancer progression. The medication helps slow the spread of cancer by targeting the mutated protein directly. It is typically prescribed after other treatments have been tried.

Side Effects

Patients taking sotorasib may experience changes in energy levels or appetite as their body adjusts to the medication. Some report mild digestive discomfort, such as nausea or diarrhea, which often improves over time. Regular monitoring by a healthcare provider is recommended to assess how the body responds to the treatment.

Precautions & Warnings

Store sotorasib tablets at room temperature away from moisture and heat. Keep the bottle tightly closed when not in use to maintain potency. Always handle the medication with clean, dry hands and avoid splitting or crushing tablets unless directed. If a dose is missed, follow the prescribed schedule and consult a healthcare professional for guidance.

Avoid Interactions

Sotorasib may interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Alcohol and grapefruit products can also affect how the drug works in the body. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Sotorasib is used to treat non-small cell lung cancer in adults with a KRAS G12C mutation.

Store sotorasib at room temperature in a tightly closed bottle away from moisture and heat.

Consult your healthcare provider before combining sotorasib with other drugs or supplements to avoid interactions.

If a dose is missed, follow your prescribed schedule and contact your healthcare provider for guidance.

Some patients report mild digestive discomfort or changes in energy levels while taking sotorasib.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.